PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CSPC Pharmaceutical Group Ltd (1093.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINHK1093012172
SectorHealthcare
IndustryDrug Manufacturers—General

Highlights

Market CapHK$68.67B
EPSHK$0.52
PE Ratio10.89
PEG Ratio2.67
Revenue (TTM)HK$31.45B
Gross Profit (TTM)HK$21.14B
EBITDA (TTM)HK$7.87B
Year RangeHK$5.20 - HK$7.93
Target PriceHK$9.71

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CSPC Pharmaceutical Group Ltd

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in CSPC Pharmaceutical Group Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-5.00%0.00%5.00%10.00%15.00%20.00%25.00%30.00%NovemberDecember2024FebruaryMarchApril
5.03%
19.54%
1093.HK (CSPC Pharmaceutical Group Ltd)
Benchmark (^GSPC)

S&P 500

Returns By Period

CSPC Pharmaceutical Group Ltd had a return of -16.67% year-to-date (YTD) and -22.98% in the last 12 months. Over the past 10 years, CSPC Pharmaceutical Group Ltd had an annualized return of 0.31%, while the S&P 500 had an annualized return of 10.55%, indicating that CSPC Pharmaceutical Group Ltd did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-16.67%6.30%
1 month-5.91%-3.13%
6 months5.03%19.37%
1 year-22.98%22.56%
5 years (annualized)-15.04%11.65%
10 years (annualized)0.31%10.55%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-20.94%6.62%0.49%
2023-0.32%18.99%3.22%2.98%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 1093.HK is 23, indicating that it is in the bottom 23% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of 1093.HK is 2323
CSPC Pharmaceutical Group Ltd(1093.HK)
The Sharpe Ratio Rank of 1093.HK is 1919Sharpe Ratio Rank
The Sortino Ratio Rank of 1093.HK is 1919Sortino Ratio Rank
The Omega Ratio Rank of 1093.HK is 2121Omega Ratio Rank
The Calmar Ratio Rank of 1093.HK is 3333Calmar Ratio Rank
The Martin Ratio Rank of 1093.HK is 2323Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for CSPC Pharmaceutical Group Ltd (1093.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


1093.HK
Sharpe ratio
The chart of Sharpe ratio for 1093.HK, currently valued at -0.64, compared to the broader market-2.00-1.000.001.002.003.00-0.64
Sortino ratio
The chart of Sortino ratio for 1093.HK, currently valued at -0.78, compared to the broader market-4.00-2.000.002.004.006.00-0.78
Omega ratio
The chart of Omega ratio for 1093.HK, currently valued at 0.91, compared to the broader market0.501.001.500.91
Calmar ratio
The chart of Calmar ratio for 1093.HK, currently valued at -0.29, compared to the broader market0.001.002.003.004.005.00-0.29
Martin ratio
The chart of Martin ratio for 1093.HK, currently valued at -1.11, compared to the broader market0.0010.0020.0030.00-1.11
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.92, compared to the broader market-2.00-1.000.001.002.003.001.92
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.78, compared to the broader market-4.00-2.000.002.004.006.002.78
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.501.001.501.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.47, compared to the broader market0.001.002.003.004.005.001.47
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.64, compared to the broader market0.0010.0020.0030.007.64

Sharpe Ratio

The current CSPC Pharmaceutical Group Ltd Sharpe ratio is -0.64. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-0.64
1.91
1093.HK (CSPC Pharmaceutical Group Ltd)
Benchmark (^GSPC)

Dividends

Dividend History

CSPC Pharmaceutical Group Ltd granted a 4.13% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.25 per share.


PeriodTTM20232022202120202019201820172016201520142013
DividendHK$0.25HK$0.25HK$0.20HK$0.17HK$0.16HK$0.09HK$0.08HK$0.06HK$0.06HK$0.05HK$0.04HK$0.05

Dividend yield

4.13%3.44%2.44%2.07%2.05%0.50%0.69%0.40%0.69%0.66%0.61%0.85%

Monthly Dividends

The table displays the monthly dividend distributions for CSPC Pharmaceutical Group Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024HK$0.00HK$0.00HK$0.00
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.11HK$0.00HK$0.00HK$0.14HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.10HK$0.00HK$0.00HK$0.00HK$0.10HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.09HK$0.00HK$0.00HK$0.00HK$0.08HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.13HK$0.00HK$0.00HK$0.04HK$0.00HK$0.00HK$0.00
2019HK$0.00HK$0.00HK$0.00HK$0.00HK$0.09HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2018HK$0.00HK$0.00HK$0.00HK$0.00HK$0.08HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2017HK$0.00HK$0.00HK$0.00HK$0.00HK$0.06HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2016HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.06HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2015HK$0.00HK$0.00HK$0.00HK$0.00HK$0.05HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2014HK$0.00HK$0.00HK$0.00HK$0.00HK$0.04HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2013HK$0.05HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%4.1%
CSPC Pharmaceutical Group Ltd has a dividend yield of 4.13%, which is quite average when compared to the overall market.
Payout Ratio
20.0%40.0%60.0%80.0%100.0%120.0%48.1%
CSPC Pharmaceutical Group Ltd has a payout ratio of 48.08%, which is quite average when compared to the overall market. This suggests that CSPC Pharmaceutical Group Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-74.29%
-3.40%
1093.HK (CSPC Pharmaceutical Group Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the CSPC Pharmaceutical Group Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the CSPC Pharmaceutical Group Ltd was 78.03%, occurring on Jun 5, 2012. Recovery took 386 trading sessions.

The current CSPC Pharmaceutical Group Ltd drawdown is 74.29%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-78.03%Apr 28, 2010522Jun 5, 2012386Dec 30, 2013908
-77.52%Jun 6, 20181312Oct 4, 2023
-74.32%Jun 20, 2003738Jun 13, 2006235May 25, 2007973
-72.98%Oct 4, 2007260Oct 27, 2008213Sep 4, 2009473
-72.06%Sep 14, 1999495Sep 18, 2001331Jan 22, 2003826

Volatility

Volatility Chart

The current CSPC Pharmaceutical Group Ltd volatility is 8.04%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%16.00%NovemberDecember2024FebruaryMarchApril
8.04%
3.62%
1093.HK (CSPC Pharmaceutical Group Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of CSPC Pharmaceutical Group Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items